ProfileGDS5822 / ILMN_1247447
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 15% 43% 11% 48% 29% 9% 5% 13% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 111.615
GSM1276600PDAC Late Ablation Control 221.443
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 1911
GSM1276603PDAC Late Ablation 221.848
GSM1276604PDAC Late Ablation 315.229
GSM1303940PDAC Late Ablation_anti-CTLA4 19.29
GSM1303941PDAC Late Ablation_anti-CTLA4 24.35
GSM1303942PDAC Late Ablation_anti-CTLA4 37.813